Quarterly ResultMay 7, 2026, 07:11 AM
Zoetis Q1 Revenue $2.3B, EPS $1.42; Revises FY26 Guidance
AI Summary
Zoetis Inc. reported first-quarter 2026 revenue of $2.3 billion, a 3% increase year-over-year, with net income at $601 million and diluted EPS at $1.42. Adjusted net income rose 2% to $646 million, with adjusted diluted EPS up 9% to $1.53. The company faced a challenging operating environment with increased pet owner price sensitivity and intensified competition, leading to an 8% decline in U.S. segment revenue, while international revenue grew 17%. Zoetis revised its full-year 2026 revenue guidance to $9.680 - $9.960 billion and adjusted diluted EPS guidance to $6.85 - $7.00, while also announcing the acquisition of Neogen's animal genomics business.
Key Highlights
- Zoetis Q1 2026 Revenue $2.3 billion, up 3% YoY (flat organic operational)
- Q1 2026 Net Income $601 million, flat YoY; Diluted EPS $1.42, up 6% YoY
- Q1 2026 Adjusted Net Income $646 million, up 2% YoY; Adjusted Diluted EPS $1.53, up 9% YoY
- Revises Full Year 2026 Revenue Guidance to $9.680 - $9.960 billion (2% to 5% organic operational growth)
- Revises Full Year 2026 Adjusted Diluted EPS Guidance to $6.85 to $7.00
- US segment revenue decreased 8% to $1.1 billion due to softer demand and competition
- International segment revenue increased 17% to $1.1 billion (10% organic operational)
- Zoetis entered into a definitive agreement to acquire Neogen's animal genomics business